6 Weeks with the von Rosen splint is sufficient for treatment of neonatal hip instability

Henrik Lauge-Pedersen1, Johan Gustafsson, Gunnar Hägglund

  • 1Department of Orthopedics, Lund University Hospital, Lund, Sweden. Henrik.Lauge-Pedersen@ort.lu.se

Acta Orthopaedica
|June 6, 2006
PubMed

Insights

A 6-week von Rosen splint treatment effectively prevents developmental dysplasia of the hip (DDH) in newborns. This approach significantly reduces late hip dislocations and dysplasia, ensuring better long-term outcomes for infants with unstable hips.

Area of Science:

  • Orthopedic Surgery
  • Pediatric Orthopedics
  • Developmental Dysplasia of the Hip (DDH)

Background:

  • Optimal treatment duration for unstable neonatal hips remains debated.
  • A 10-year hospital protocol utilizes a 6-week von Rosen splint for all unstable hips (subluxatable, Barlow-positive, Ortolani-positive).

Purpose of the Study:

  • To evaluate the efficacy of a standardized 6-week von Rosen splint treatment program for unstable neonatal hips.
  • To assess the long-term outcomes, including late dysplasia and dislocation, in infants treated with this protocol.

Main Methods:

  • Retrospective analysis of 32,171 live births between 1988 and 1997.
  • Diagnosis and treatment of 247 infants with clinically unstable hips using a von Rosen splint for 6 weeks.
  • Radiographic follow-up conducted on 223 children after 5-15 years.

Main Results:

  • Only one patient (0.4%) required operative treatment for a dislocated hip after initial splinting.
  • One patient who did not adhere to the treatment program developed hip dislocation at age 3.
  • Four patients needed treatment beyond the standard 6 weeks.
  • No cases of late hip dysplasia or dislocation were observed at long-term follow-up in the treated cohort.

Conclusions:

  • A 6-week treatment with the von Rosen splint is highly effective in preventing late hip dysplasia and dislocation.
  • The current screening and treatment protocol demonstrates excellent long-term results for managing unstable neonatal hips.
  • This standardized approach minimizes the need for further interventions and adverse outcomes in developmental dysplasia of the hip (DDH).
Abstract